New thoughts on the pathobiology of regimen-related mucosal injury

被引：26
|
作者：
Anthony, Lowell
Bowen, Joanne
Garden, Adam
Hewson, Ian
Sonis, Stephen
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Royal Melbourne Hosp, Parkville, Vic 3050, Australia
[3] LSUHSC, Stanley S Scott Canc Ctr, New Orleans, LA USA
[4] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia
[5] Royal Adelaide Hosp, Dept Med Oncol, Adelaide, SA 5000, Australia
[6] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
SUPPORTIVE CARE IN CANCER | 2006年 / 14卷 / 06期
关键词：
mucosal injury; cancer theraphy; radiation; drugs; genetic influences;
D O I：
10.1007/s00520-006-0058-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Our understanding of the biological basis for mucosal barrier injury (mucositis) induced by cancer therapy with radiation or drugs continues to evolve. A patient's mucosal response to cancer therapy appears to be controlled by both global (i.e. gender, underlying systemic disease, race) and tissue specific (i.e. epithelial type, intrinsic endocrine system, local microbial environment, function) factors. Conclusion: Interactions of these elements, coupled with underlying genetic influences, most likely govern the risk, course and severity of regimen-related mucosal injury.
引用
收藏
页码：516 / 518
页数：3
相关论文
共 50 条
  • [31] A RANDOMIZED CONTROLLED TRIAL OF PENTOXIFYLLINE FOR THE PREVENTION OF REGIMEN-RELATED TOXICITIES IN PATIENTS UNDERGOING ALLOGENEIC MARROW TRANSPLANTATION
    CLIFT, RA
    BIANCO, JA
    APPELBAUM, FR
    BUCKNER, CD
    SINGER, JW
    BAKKE, L
    BENSINGER, WI
    BOWDEN, RA
    MCDONALD, GB
    SCHUBERT, M
    SHIELDS, AF
    SLATTERY, JT
    STORB, R
    FISHER, LD
    MORI, M
    THOMAS, ED
    HANSEN, JA
    [J]. BLOOD, 1993, 82 (07) : 2025 - 2030
  • [32] Insulin-Using Patients Experience Comparable Reductions in Regimen-Related Distress from Behavioral Interventions
    Hambidge, Bertha B.
    Cummings, Doyle M.
    Lutes, Lesley
    Carraway, Marissa
    Patil, Shivajirao
    Adams, Alyssa
    Solar, Chelsey
    Littlewood, Kerry
    Edwards, Sheila
    Gatlin, Peggy
    [J]. DIABETES, 2017, 66 : A207 - A207
  • [33] Busulphan dose, regimen-related toxicity and outcome of patients treated with immune ablation and stem cell transplantation
    Atkins, H. L.
    Freedman, M. S.
    Hilliker, C.
    McDiarmid, S.
    [J]. MULTIPLE SCLEROSIS, 2007, 13 : S248 - S248
  • [34] Lace(lomustine, ARA-C, cyclophosphamide and etoposide): An effective conditioning regimen for autologous and allogeneic transplantation with minimal regimen-related toxicity
    Orchard, K
    Lyttelton, MP
    Abrahamson, G
    Stem, S
    Abboudi, Z
    McGuigan, D
    Giles, C
    Kanfer, EJ
    Samson, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 969 - 969
  • [35] Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity?
    H Khoury
    D Adkins
    R Brown
    K Trinkaus
    R Vij
    G Miller
    LT Goodnough
    J DiPersio
    [J]. Bone Marrow Transplantation, 2000, 25 : 737 - 743
  • [36] Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity?
    Khoury, H
    Adkins, D
    Brown, R
    Trinkaus, K
    Vij, R
    Miller, G
    Goodnough, LT
    DiPersio, J
    [J]. BONE MARROW TRANSPLANTATION, 2000, 25 (07) : 737 - 743
  • [37] Regimen-related toxicity after fludarabine–melphalan conditioning: a prospective study of 31 patients with hematologic malignancies
    K van Besien
    S Devine
    A Wickrema
    E Jessop
    K Amin
    M Yassine
    V Maynard
    W Stock
    D Peace
    F Ravandi
    Y-H Chen
    R Hoffman
    J Sossman
    [J]. Bone Marrow Transplantation, 2003, 32 : 471 - 476
  • [38] REGIMEN-RELATED ACUTE TOXICITIES - PATHOPHYSIOLOGY, RISK-FACTORS, CLINICAL-EVALUATION AND PREVENTIVE STRATEGIES
    KLINGEMANN, HG
    SHEPHERD, JD
    REECE, DE
    BARNETT, MJ
    NANTEL, SH
    SUTHERLAND, HJ
    SPINELLI, JJ
    PHILLIPS, GL
    [J]. BONE MARROW TRANSPLANTATION, 1994, 14 : S14 - S18
  • [39] Fluconazole coadministration concurrent with cyclophosphamide conditioning may reduce regimen-related toxicity postmyeloablative hematopoietic cell transplantation
    Upton, Arlo
    McCune, Feannine S.
    Kirby, Katharine A.
    Leisenring, Wendy
    McDonald, George
    Batchelder, Ami
    Marr, Kieren A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (07) : 760 - 764
  • [40] LACE (lomustine, ara-C, cyclophosphamide and etoposide): An effective conditioning regimen for autologous and allogeneic transplantation with minimal regimen-related toxicity.
    Orchard, K
    Lyttelton, MP
    Abrahamson, G
    Stern, S
    Abboudi, Z
    McGuigan, D
    Giles, C
    Kanfer, EJ
    Samson, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 174 - 174
12345